Prostate and urethral dosimetry in high dose rate brachytherapy for prostate cancer

Prostate and urethral dosimetry in high dose rate brachytherapy for prostate cancer - Prostate and urethral dosimetry in high dose rate brachytherapy for prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005123

Enrollment

Registered

2011-03-01

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measument of prostatic tissue and urethral doses in HDR brachytherapy for prostate cancer

Interventions

real time dosimetry

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who recieve HDR brachytherapy for prostate cancer

Exclusion criteria

Exclusion criteria: Judged as being unsuitable for trial by the doctor

Design outcomes

Primary

Measure	Time frame
Differences between measured and calculated doses in HDR brachytherapy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026